PURPOSE: To report a novel, identical nonsense mutation in the rhodopsin (RHO) gene in two Indonesian families with autosomal recessive retinitis pigmentosa (arRP). METHODS: Mutation screening for the RHO gene was performed in 38 unrelated patients with retinitis pigmentosa (RP) by direct sequencing. Clinical features were also characterized, through complete ophthalmologic examination. Family members of RP patients testing positive for the RHO gene were subjected to genetic and clinical examination. To assess the founder effect in the two families, haplotype analysis also was performed. RESULTS: A novel homozygous nonsense mutation was detected in two patients by a G to A transition at nucleotide position 482 in exon 2 of the RHO gene, resulting in substitution of a tryptophan-to-stop at codon 161 (c.482G>A, p.W161X). Examination of family members of these 2 patients showed that the affected members were homozygous and unaffected carriers were heterozygous for the p.W161X mutation. Haplotype analysis revealed that members of the two families carried the same disease-associated variants in markers (IVS1 RHO and D3S2322). No p.W161X mutations were detected in 45 normal Indonesian subjects, nor were any mutations detected in exons 1-5 of the RHO gene in the remaining 36 RP patients. CONCLUSION: We detected a novel, recessive nonsense mutation (p.W161X) in the RHO gene of two families through mutation screening of RHO in 38 Indonesian RP patients. Haplotype analysis suggested that p.W161X was the founder mutation.
PURPOSE: To report a novel, identical nonsense mutation in the rhodopsin (RHO) gene in two Indonesian families with autosomal recessive retinitis pigmentosa (arRP). METHODS: Mutation screening for the RHO gene was performed in 38 unrelated patients with retinitis pigmentosa (RP) by direct sequencing. Clinical features were also characterized, through complete ophthalmologic examination. Family members of RP patients testing positive for the RHO gene were subjected to genetic and clinical examination. To assess the founder effect in the two families, haplotype analysis also was performed. RESULTS: A novel homozygous nonsense mutation was detected in two patients by a G to A transition at nucleotide position 482 in exon 2 of the RHO gene, resulting in substitution of a tryptophan-to-stop at codon 161 (c.482G>A, p.W161X). Examination of family members of these 2 patients showed that the affected members were homozygous and unaffected carriers were heterozygous for the p.W161X mutation. Haplotype analysis revealed that members of the two families carried the same disease-associated variants in markers (IVS1 RHO and D3S2322). No p.W161X mutations were detected in 45 normal Indonesian subjects, nor were any mutations detected in exons 1-5 of the RHO gene in the remaining 36 RP patients. CONCLUSION: We detected a novel, recessive nonsense mutation (p.W161X) in the RHO gene of two families through mutation screening of RHO in 38 Indonesian RP patients. Haplotype analysis suggested that p.W161X was the founder mutation.
Authors: Theodore G Wensel; Zhixian Zhang; Ivan A Anastassov; Jared C Gilliam; Feng He; Michael F Schmid; Michael A Robichaux Journal: Prog Retin Eye Res Date: 2016-06-22 Impact factor: 21.198
Authors: Anna M Siemiatkowska; Kentar Arimadyo; Luminita M Moruz; Galuh D N Astuti; Marta de Castro-Miro; Marijke N Zonneveld; Tim M Strom; Ilse J de Wijs; Lies H Hoefsloot; Sultana M H Faradz; Frans P M Cremers; Anneke I den Hollander; Rob W J Collin Journal: Mol Vis Date: 2011-11-18 Impact factor: 2.367
Authors: Miguel de Sousa Dias; Imma Hernan; Barbara Delás; Beatriz Pascual; Emma Borràs; Maria José Gamundi; Begoña Mañé; Patricia Fernández-San José; Carmen Ayuso; Miguel Carballo Journal: Mol Vis Date: 2015-08-18 Impact factor: 2.367